Efficacy of Bifidobacterium longum and Lactobacillus plantarum (NVP-1703) in Children With Allergic Rhinitis: A

Kyunguk Jeong1, Seok Won Jang2, Se-Ah Jeon1

  • 1Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea.

PubMed

Insights

This study found that probiotics containing Bifidobacterium longum and Lactobacillus plantarum significantly reduced allergic rhinitis symptoms and improved quality of life in children. The treatment was safe and well-tolerated, showing promising results for managing pediatric allergic rhinitis.

Area of Science:

  • Immunology
  • Microbiology
  • Pediatrics

Background:

  • Allergic rhinitis (AR) is a common condition in children.
  • Probiotics show potential for AR treatment, but evidence is mixed.
  • The safety and efficacy of specific probiotic strains need further investigation.

Purpose of the Study:

  • To evaluate the therapeutic effects of a Bifidobacterium longum and Lactobacillus plantarum mixture (NVP-1703) in children with perennial allergic rhinitis.
  • To assess the safety profile of NVP-1703 in the pediatric population.
  • To investigate the impact of NVP-1703 on allergic inflammatory markers.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial was conducted.
  • Participants included children aged 6-19 years with perennial AR.
  • Treatment involved NVP-1703 (1 × 10^10 CFU/day) or placebo for 4 weeks, with symptom scores, quality of life, and inflammatory markers assessed.

Main Results:

  • NVP-1703 significantly reduced total nasal symptom scores (TNSS) and nasal symptom duration scores (NSDS) compared to placebo.
  • Quality of life improved, particularly regarding mouth breathing and itchy nose.
  • Reduced ratios of IL-4/IL-22 and IL-5/IL-22 were observed, indicating modulation of allergic inflammation.
  • No significant adverse events were reported with NVP-1703.

Conclusions:

  • Oral NVP-1703 effectively improves allergic rhinitis symptoms and quality of life in children.
  • The probiotic mixture modulates T helper 2 cytokine responses.
  • NVP-1703 presents a safe and effective therapeutic option for pediatric perennial allergic rhinitis.
Abstract

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
299
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
68
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
144